Here are relevant reports on : artificial-intelligence-in-scientific-research-market
-
Artificial Joints Market - Global Forecast to 2030
The market outlook for the artificial joints market is expected to be positive in the coming years. Artificial joints, also known as prosthetic joints, are medical devices used to replace damaged or diseased joints in the body, such as hips, knees, shoulders, and elbows. These devices help restore mobility and improve the quality of life for individuals suffering from joint conditions or injuries.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cloud Business Intelligence Market: Worldwide Forecasts and Analysis (2014 – 2019)
Cloud Business Intelligence (BI) is a combination of technologies, tools and solutions that employ one or more cloud deployment models. Business intelligence on cloud is a delivery model that is being watched by many organizations as it offers several advantages in terms of cost benefits, flexibility of implementation, availability and speed of implementation. Cloud computing and business intelligence is an ideal match as business intelligence is about transforming data into information that businesses can use to make better decisions, while cloud computing provides an efficient and agile way to access business intelligence solutions. IBM, SAP, SAS, Salesforce.com, Microsoft, and Oracle are the major players in the cloud business intelligence market. These vendors offer their solutions catering to several industry verticals such as BFSI, retail, healthcare and life sciences, IT and telecommunication, government and public sector, research and education, manufacturing, travel and hospitality, media and communication, and others. The report provides global market trends, overall adoption scenario, competitive landscape, key drivers, restraints, concerns and opportunities in this market. The report aims at estimating the current market size and the future growth potential of this market across various verticals and regions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Generative AI Outlook 2025 – Shaping the Future of Creative Intelligence
Global IT spending on devices, data center systems, enterprise software, IT services, and communications services is forecast to reach USD 5.7 trillion by 2025 (9.3% growth over 2024). OpenAI, Microsoft, Google, AWS, and Adobe are the major players in generative AI, with more than 45% combined market share in 2024. Other prominent market players are NVIDIA, Meta, Anthropic, Accenture, and IBM. In 2024, key generative AI providers strive to maintain their leadership positions with new product launches & product enhancements, multimodal AI advancements, strategic deals, and partnerships & collaborations. In 2025, Generative AI providers will invest in ethical AI frameworks, real-time multimodal capabilities, and AI democratization to enhance usability, address bias, and ensure data security, meeting the growing demand for personalized, transparent, and scalable AI solutions across industries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028
The global research antibodies & reagents market, valued at US$1.3 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 45.6% from 2023 to 2028, culminating in a forecasted valuation of US$12.1 billion by the end of the period. The growth of this market is largely driven by an increase in research activity—especially in the life sciences industry—along with growing industry-academia collaborations are a primary growth driver for this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Neuromarketing Tools, Technologies, & Services Market by Tool (Hardware Solution, Software Platform), Technology (EEG & Brainware Monitoring, Biometric & Physiological Monitoring), End Users (Clinical Research, Consumer Research) - Global Forecast to 2030
The neuromarketing tools, technologies, and services market is segmented by tools (hardware solutions like EEG amplifiers, eye-tracking, biometric devices, and software platforms), technologies (EEG & brainwave monitoring, eye-tracking, biometric & physiological monitoring), and end users (commercial & enterprise solutions, consumer research, academic & clinical research, and others). Market estimates are derived through extensive secondary and primary research, applying top-down and bottom-up approaches with data triangulation. The study covers global and regional market dynamics, competitive landscape, and forecasts up to 2030, profiling key players such as Tobii AB, iMotions, EMOTIV, Brain Products, Smart Eye, and others.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
The global cell sorting market is projected to grow at a CAGR of 7.0%. Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers Market, valued at US$16.40 billion in 2024, stood at US$17.46 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$28.11 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Asia Pacific biomarkers Market, valued at US$13.51 billion in 2024, stood at US$14.73 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$26.40 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
North America Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)-Forecast to 2030
The North America biomarkers Market, valued at US$23.35 billion in 2024, stood at US$25.13 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$45.25 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
